Background <p>Technological advancements have significantly reshaped modern surgical practices, with Transoral Robotic Surgery (TORS) emerging as a transformative tool in Oral and Maxillofacial Surgery (OMFS). Its precision, minimally invasive approach and improved patient outcomes have led to its increasing adoption in clinical settings. However, the optimal scope, justification and feasibility of TORS – particularly in resource-constrained settings – remain areas of ongoing debate.</p> Objective <p>This narrative review aims to critically evaluate the role of TORS in OMFS from a surgeon’s perspective, with emphasis on clinical indications, functional outcomes, training requirements, cost-effectiveness, and future research directions.</p> Methods <p>A targeted narrative literature search was conducted across PubMed, Scopus, and the Cochrane Library for English-language, peer-reviewed articles published between January 2000 and March 2026 (final search date: March 31, 2026). The search utilized keywords including “TORS,” “oral and maxillofacial surgery,” and “robotic reconstruction.” Article selection was guided by relevance to OMFS clinical application rather than formal eligibility scoring. Inclusion was restricted to clinical studies and reviews detailing OMFS robotic applications, functional outcomes, or cost-effectiveness. Given the narrative nature of this review, formal systematic review protocols, including predefined eligibility frameworks and meta-analytic synthesis, were not applied.</p> Results <p>TORS provides enhanced instrument dexterity and visualization, facilitating precise access to anatomically complex regions. It offers benefits such as reduced scarring, decreased postoperative morbidity, and faster recovery, aligning well with patient preferences. Surgeons report increased confidence and control, reinforcing the value of robotic systems in expanding surgical possibilities. However, its routine application across all oral and maxillofacial procedures is not justified, as these advantages are primarily supported by retrospective cohort studies and systematic reviews, with limited high-level randomized evidence. High costs, substantial infrastructure requirements, training limitations, and issues of equitable access restrict widespread adoption, especially in public healthcare systems. Current robotic platforms function primarily as surgeon-controlled systems, and progression toward higher levels of autonomy remains limited by technical, ethical, and regulatory challenges.</p> Conclusion <p>TORS represents a paradigm shift in OMFS, where the synergy between surgical expertise and robotic innovation enhances both technical performance and patient care. As technology continues to evolve, the role of the oral and maxillofacial surgeon will increasingly involve adaptation, training, and leadership in the integration of robotic systems into mainstream practice. Future advances should focus on evidence-based expansion, functional outcome optimization, and addressing key research gaps related to autonomy, accessibility, and cost-effectiveness.</p>